Healthcare news and intelligence for Southern Africa
Daily reporting for the pharmaceutical, medical scheme and hospital sectors, published by Health Matters since 1994.
28.10.2026
Medical scheme increases in 2027 range from 7.35% to 8.9%. Ageing members, chronic illness and medicine costs drive contributions higher.
Latest
25.10.2026
More news
25.10.2026
Clicks' growth strategy targets GLP-1 medicines, oncology, medical consumables, and digital pharmacy to diversify beyond retail stores.
23.10.2026
The High Court set aside R12.6bn in TLD contracts in the ARV tender, ordering Cipla’s inclusion and excluding Viatris and Innovata.
23.10.2026
Experts warn that opioid overprescribing after minor surgery risks addiction and waste, and paracetamol and NSAIDs often suffice.
23.10.2026
Clicks annual results show turnover topping R50bn, while UPD faced margin pressure from the smaller medicine price increase.
22.10.2026
Treasury's MTBPS warns that weak controls, unpaid bills and medico-legal claims in provincial health departments pose a serious fiscal risk.
20.10.2026
India's new cap on cancer drug prices will cut costs for 137 medicines by up to 70%, impacting hospitals and drugmakers.
20.10.2026
IGAD, SADC, and other regional blocs plan to boost health emergency preparedness through shared surveillance, workforce, and financing.
19.10.2026
The Supreme Court ruling on RAF medical expense claims ensures treatment costs are not reduced by prior medical scheme payments.
19.10.2026
Explore NHI implementation and its impact on healthcare rights, funding, and legal scrutiny in the evolving healthcare landscape.
19.10.2026
Gain insights into medical indemnity and its role in balancing financial risks for public health departments and private providers.
18.10.2026
The medicine price increase could add R1bn to medical scheme spending in 2027, with implications for budgets, contributions and members.
The archive
Browse every Health Matters article by month.